<DOC>
	<DOCNO>NCT00778895</DOCNO>
	<brief_summary>Children young 5 year age high risk severe influenza disease ( flu ) hospitalization due flu . Scientists process re-evaluating dose initially base whole virus vaccine improve efficacy infant . In study , compare two different dose level GSK1557482A flu vaccine . Another already approve flu vaccine make different company use control .</brief_summary>
	<brief_title>Clinical Study Children , 6 Months 3 Years Age , Assess Two Dose Levels Experimental Flu Vaccine , Using Licensed Influenza Virus Vaccine , Vaxigrip® Control</brief_title>
	<detailed_description>This study two different dose level new formulation flu vaccine 2008/2009 flu season use World Health Organization recommend virus strain . Subjects randomly put one three different group receive either one two dos : 0.25 mL dose new flu vaccine , 0.5 mL dose new flu vaccine license Vaxigrip flu vaccine ( control ) The parent subject study doctor nurse know group child study complete . The child vaccinate either one dose two dos depend whether receive flu vaccine . The doctor decide schedule child base information provide parent . The active phase study last approximately two month child receive two dos one month receive single dose . An extended safety follow-up continue Study Month 6 . Two blood sample take subject . These used evaluate well vaccine work child dose level work best compare control . The parent fill diary card four day record reaction symptom may occur vaccination . Parents also keep record symptom may occur vaccination six month first vaccination keep record medication child take time period .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female child 6 month &lt; 3 year age time vaccination , regardless previous administration influenza vaccine previous season ; Subjects must good health establish medical history physical examination enter study ; Subjects parent/guardian investigator believe comply requirement protocol enrol study ; Written inform consent obtain subject 's parent/guardian . Parents/guardian access consistent mean telephone contact , land line mobile Use investigational nonregistered product ( drug vaccine ) within 30 day precede administration study vaccine plan use study period . Routine , register childhood vaccination exclusion criterion ; History hypersensitivity vaccine ; History allergy reaction likely exacerbate , component vaccine include egg , chicken protein , formaldehyde , sodium deoxycholate ; History congenital , acquire , iatrogenic immunodeficiency state ( current potential ) include HIV infection , disorder lymphoid system bone marrow , chronic administration ( define 14 consecutive day ) immunosuppressant immunemodifying drug within 3 month prior administration study vaccine . Acute disease time enrolment . History Guillain Barré syndrome within 6 week receipt prior inactivate influenza virus vaccine ; Any significant disorder blood coagulation treatment vitamin K antagonists ; know disorder hemostasis ; Receipt immunoglobulins and/or blood product within three month study enrollment plan administration product study period . Receipt nonstudy relate influenza vaccine outside study current ( 200809 ) influenza immunization campaign . Any use analgesics/antipyretics 12 hour receipt vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Flu</keyword>
	<keyword>Safety</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Flu vaccine</keyword>
	<keyword>Influenza</keyword>
	<keyword>Virus</keyword>
</DOC>